ltrasound guided injection of hyaluronic acid versus platelet rich plasma in management of plantar fasciitis refractory to conservative management

Department of anaesthesiology and critical careJNMCH AMU ALIGARH0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年5月2日

试验速览

暂无简介。

•1.Age > 18 years and <60yrs.
•2.Patients of plantar fascitis of atleast 6 weeks duration.
•3.Patientâ??s pain refractory to primary conservative treatments (NRS >5).
•4.Willingness to participate in the study and forgo any other concomitant treatment modality.

•1.Unwillingness to participate in the study.
•2.Arthrosis or arthritis of foot, old-healed tendoachilles rupture.
•3.History of foot trauma or Surgery.
•4.History of injection in the involved foot during preceding 6 months.
•5.Patients with history of vascular insufficiency, neuropathic heel pain, on anti-platelet or anticoagulant therapy, and on aspirin containing NSAIDS.
•6.Any foot and ankle deformity including pes planus or pes cavus.
•7.Pregnant and Breastfeeding females.
•8.Uncontrolled psychiatric disorder or major depression or other severe medical illness.
•9.Local infection or ongoing septicaemia.
•10.Patients with autoimmune disease, malignancy, uncontrolled diabetes mellitus, hyperlipidemia and patients with BMI >30.

发起方

Department of anaesthesiology and critical careJNMCH AMU ALIGARH